Kevin McNally BSc (Hons) MCOptom LVA

Research Interests

• Visual Impairment remediation.
• Accurate measurement of vision and its interpretation.

Teaching

• 1-2 sessions per week term time clinical teaching of under graduate and post graduate optometrists at Hinchingbrooke NHS trust.

• Occasional clinical supervision at Anglia Ruskin University optometry clinic.

Current research

• IVAN ( Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration) study Investigator and coordinator at Addenbrookes Cambridge University Hospital NHS trust.

Publications

• K McNally, K Latham, C Gonzalez Alvarez, A Subramanian, S Pardhan. A comparative evaluation of Nidek MP1 microperimetry to the Humphrey VFA 24-2 program in normals and macular disease Proceedings of the 9th International Conference on Low Vision, Vision 2008, Montreal, Quebec, Canada

• K McNally, K Latham, K Lindenbaum. Microperimetry and Optical Coherence Tomography in a district general hospital eye clinic: valuable additions to differential diagnosis or just too many toys? Proceedings of the 9th International Conference on Low Vision, Vision 2008, Montreal, Quebec, Canada

• K Latham, K McNally. Which is the Better Eye? Proceedings of the 9th International Conference on Low Vision, Vision 2008, Montreal, Quebec, Canada

• Usha Chakravarthy, Simon P. Harding Chris A. Rogers, Susan M. Downes, Andrew J. Lotery, Sarah Wordsworth, Barnaby C. Reeves, Douglas Newman, Kevin McNally Et Al; Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration One-Year Findings from the IVAN Randomized Trial. ARVO 2012. Fort Lauderdale,Florida, USA.